Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)
USD 2.16
(0.46%)
USD 2.16
(0.46%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 8.22 Billion CNY | -0.33% |
| 2022 | 8.24 Billion CNY | 19.42% |
| 2021 | 6.9 Billion CNY | 4.6% |
| 2020 | 6.6 Billion CNY | -5.58% |
| 2019 | 6.99 Billion CNY | 9.99% |
| 2018 | 6.35 Billion CNY | 11.77% |
| 2017 | 5.68 Billion CNY | -7.92% |
| 2016 | 6.17 Billion CNY | -12.74% |
| 2015 | 7.08 Billion CNY | -0.09% |
| 2014 | 7.08 Billion CNY | 17.92% |
| 2013 | 6.01 Billion CNY | 17.16% |
| 2012 | 5.12 Billion CNY | 16.8% |
| 2011 | 4.39 Billion CNY | 26.44% |
| 2010 | 3.47 Billion CNY | 20.57% |
| 2009 | 2.88 Billion CNY | 21.79% |
| 2008 | 2.36 Billion CNY | 4.73% |
| 2007 | 2.25 Billion CNY | 5.04% |
| 2006 | 2.14 Billion CNY | -14.59% |
| 2005 | 2.51 Billion CNY | 18.97% |
| 2004 | 2.11 Billion CNY | 2.5% |
| 2003 | 2.06 Billion CNY | 12.23% |
| 2002 | 1.83 Billion CNY | 20.85% |
| 2001 | 1.52 Billion CNY | 85.01% |
| 2000 | 822.64 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 1.64 Billion CNY | -12.4% |
| 2024 Q2 | 1.87 Billion CNY | -9.9% |
| 2024 Q1 | 2.08 Billion CNY | -14.15% |
| 2023 FY | 8.22 Billion CNY | -0.33% |
| 2023 Q3 | 1.7 Billion CNY | -11.85% |
| 2023 Q4 | 2.42 Billion CNY | 42.5% |
| 2023 Q1 | 2.15 Billion CNY | -19.8% |
| 2023 Q2 | 1.93 Billion CNY | -10.23% |
| 2022 FY | 8.24 Billion CNY | 19.42% |
| 2022 Q1 | 1.88 Billion CNY | 21.47% |
| 2022 Q4 | 2.68 Billion CNY | 50.22% |
| 2022 Q3 | 1.78 Billion CNY | -5.16% |
| 2022 Q2 | 1.88 Billion CNY | -0.2% |
| 2021 Q3 | 1.71 Billion CNY | -5.61% |
| 2021 FY | 6.9 Billion CNY | 4.6% |
| 2021 Q4 | 1.55 Billion CNY | -9.14% |
| 2021 Q1 | 1.82 Billion CNY | 10.95% |
| 2021 Q2 | 1.81 Billion CNY | -0.73% |
| 2020 Q2 | 1.63 Billion CNY | -1.3% |
| 2020 Q1 | 1.65 Billion CNY | -8.83% |
| 2020 Q3 | 1.66 Billion CNY | 1.96% |
| 2020 FY | 6.6 Billion CNY | -5.58% |
| 2020 Q4 | 1.64 Billion CNY | -1.2% |
| 2019 Q2 | 1.78 Billion CNY | 1.53% |
| 2019 FY | 6.99 Billion CNY | 9.99% |
| 2019 Q3 | 1.64 Billion CNY | -7.67% |
| 2019 Q4 | 1.81 Billion CNY | 10.5% |
| 2019 Q1 | 1.75 Billion CNY | 5.01% |
| 2018 Q3 | 1.57 Billion CNY | 5.31% |
| 2018 FY | 6.35 Billion CNY | 11.77% |
| 2018 Q4 | 1.66 Billion CNY | 5.92% |
| 2018 Q2 | 1.49 Billion CNY | -7.31% |
| 2018 Q1 | 1.61 Billion CNY | 15.73% |
| 2017 Q4 | 1.39 Billion CNY | 6.86% |
| 2017 FY | 5.68 Billion CNY | -7.92% |
| 2017 Q1 | 1.46 Billion CNY | 1.87% |
| 2017 Q2 | 1.52 Billion CNY | 4.02% |
| 2017 Q3 | 1.3 Billion CNY | -14.25% |
| 2016 Q2 | 1.6 Billion CNY | -2.51% |
| 2016 Q3 | 1.49 Billion CNY | -6.72% |
| 2016 FY | 6.17 Billion CNY | -12.74% |
| 2016 Q4 | 1.43 Billion CNY | -3.85% |
| 2016 Q1 | 1.64 Billion CNY | -20.03% |
| 2015 Q2 | 1.74 Billion CNY | 7.41% |
| 2015 Q1 | 1.62 Billion CNY | -19.01% |
| 2015 Q3 | 1.66 Billion CNY | -4.45% |
| 2015 Q4 | 2.05 Billion CNY | 23.58% |
| 2015 FY | 7.08 Billion CNY | -0.09% |
| 2014 FY | 7.08 Billion CNY | 17.92% |
| 2014 Q1 | 1.55 Billion CNY | 1.07% |
| 2014 Q2 | 1.78 Billion CNY | 14.9% |
| 2014 Q3 | 1.75 Billion CNY | -1.82% |
| 2014 Q4 | 2 Billion CNY | 14.3% |
| 2013 FY | 6.01 Billion CNY | 17.16% |
| 2013 Q3 | 1.39 Billion CNY | -14.31% |
| 2013 Q4 | 1.53 Billion CNY | 9.97% |
| 2013 Q2 | 1.62 Billion CNY | 12.45% |
| 2013 Q1 | 1.44 Billion CNY | 13.68% |
| 2012 FY | 5.12 Billion CNY | 16.8% |
| 2012 Q4 | 1.27 Billion CNY | -0.03% |
| 2012 Q3 | 1.27 Billion CNY | -5.32% |
| 2012 Q2 | 1.34 Billion CNY | 9.17% |
| 2012 Q1 | 1.23 Billion CNY | 3.35% |
| 2011 Q4 | 1.19 Billion CNY | 7.47% |
| 2011 Q1 | 1.02 Billion CNY | 9.32% |
| 2011 Q3 | 1.11 Billion CNY | 4.54% |
| 2011 Q2 | 1.06 Billion CNY | 3.61% |
| 2011 FY | 4.39 Billion CNY | 26.44% |
| 2010 Q4 | 937.94 Million CNY | 2.41% |
| 2010 Q3 | 915.91 Million CNY | 4.25% |
| 2010 Q2 | 878.57 Million CNY | 18.56% |
| 2010 Q1 | 741.03 Million CNY | -9.72% |
| 2010 FY | 3.47 Billion CNY | 20.57% |
| 2009 FY | 2.88 Billion CNY | 21.79% |
| 2009 Q4 | 820.79 Million CNY | 15.65% |
| 2009 Q1 | 678.08 Million CNY | 15.84% |
| 2009 Q2 | 672.26 Million CNY | -0.86% |
| 2009 Q3 | 709.71 Million CNY | 5.57% |
| 2008 FY | 2.36 Billion CNY | 4.73% |
| 2008 Q4 | 585.37 Million CNY | 3.13% |
| 2008 Q3 | 567.6 Million CNY | -2.12% |
| 2008 Q2 | 579.91 Million CNY | -8.31% |
| 2008 Q1 | 632.45 Million CNY | 9.93% |
| 2007 FY | 2.25 Billion CNY | 5.04% |
| 2007 Q4 | 575.31 Million CNY | 17.85% |
| 2007 Q3 | 488.19 Million CNY | -18.85% |
| 2007 Q2 | 601.57 Million CNY | 1.39% |
| 2007 Q1 | 593.33 Million CNY | 16.08% |
| 2006 Q3 | 496.92 Million CNY | -22.08% |
| 2006 FY | 2.14 Billion CNY | -14.59% |
| 2006 Q2 | 637.75 Million CNY | 26.51% |
| 2006 Q4 | 511.14 Million CNY | 2.86% |
| 2006 Q1 | 504.13 Million CNY | -42.43% |
| 2005 Q4 | 875.74 Million CNY | 56.42% |
| 2005 Q3 | 559.86 Million CNY | 2.6% |
| 2005 Q2 | 545.69 Million CNY | 1.84% |
| 2005 Q1 | 535.84 Million CNY | 0.59% |
| 2005 FY | 2.51 Billion CNY | 18.97% |
| 2004 Q4 | 532.69 Million CNY | 0.26% |
| 2004 Q3 | 531.33 Million CNY | -1.49% |
| 2004 FY | 2.11 Billion CNY | 2.5% |
| 2004 Q2 | 539.35 Million CNY | 5.27% |
| 2004 Q1 | 512.36 Million CNY | -10.75% |
| 2003 FY | 2.06 Billion CNY | 12.23% |
| 2003 Q4 | 574.06 Million CNY | 37.92% |
| 2003 Q2 | 583.07 Million CNY | 18.78% |
| 2003 Q1 | 490.87 Million CNY | -25.26% |
| 2003 Q3 | 416.22 Million CNY | -28.61% |
| 2002 Q4 | 656.76 Million CNY | 89.48% |
| 2002 Q1 | 393.9 Million CNY | 0.0% |
| 2002 Q3 | 346.61 Million CNY | -21.58% |
| 2002 Q2 | 441.97 Million CNY | 12.2% |
| 2002 FY | 1.83 Billion CNY | 20.85% |
| 2001 FY | 1.52 Billion CNY | 85.01% |
| 2000 FY | 822.64 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|